324 Participants Needed

Walking Breaks for Cardiometabolic Health

KD
MM
MS
Overseen ByMaria Serafini, BS
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

The purpose of this Phase 1 research study is to answer two questions: (1) How frequent should periods of prolonged sedentary time be interrupted? and (2) What is the appropriate duration or length of time of these breaks in sedentary time? To address these questions, this project will conduct a state-of-the-art adaptive dose finding study under controlled laboratory conditions to determine the minimally effective dose (the smallest dose) that yields cardiometabolic benefit for two separate sedentary break elements (frequency and duration). Study findings will ultimately determine how often and for how long people should break up periods of prolonged sedentary time to transiently improve established cardiovascular risk factors; key foundational information critical to the success of future long-term trials and ultimately public health guidelines. Primary Aim: To determine the minimally effective dose combination(s) of frequency and duration needed to provide cardiometabolic benefit during an 8-hour experimentation period. Specifically, the study will determine: 1a. For each fixed duration, the minimum sedentary break frequency (e.g., every 30 min, 60 min, 120 min) that demonstrates a reduction in systolic BP, diastolic BP, or glucose compared with a sedentary control condition. 1b. For each fixed frequency, the minimum sedentary break duration (e.g., activity breaks of 1 min, 5 min, 10 min) that demonstrates a reduction in systolic BP, diastolic BP, or glucose compared with a sedentary control. Secondary Aim: It is also critical to public health strategy to assess the acceptability/feasibility of various sedentary break doses as too high a dose will yield poor uptake. To address this need, the maximally tolerated dose (the highest dose that does not cause undue physical/psychological distress) for frequency and duration of sedentary breaks will also be determined via assessment of 4 constructs: physical exhaustion/fatigue, affect (e.g., mood, emotion), tolerability (e.g., completion of dose protocol), and safety (e.g., hypoglycemia). Maximally tolerated dose will be defined as the highest dose where \<20% of participants exhibit an adverse outcome.

Will I have to stop taking my current medications?

The trial requires that participants do not take medication to control blood pressure or glucose, so you may need to stop these medications to participate.

What data supports the effectiveness of the treatment Walking Breaks for Cardiometabolic Health?

Research shows that taking breaks from sitting by walking can improve cardiometabolic health, as it helps reduce the risk factors associated with prolonged sitting, such as high blood sugar levels and poor heart health.12345

Is it safe for humans to take walking breaks to interrupt prolonged sitting?

Research shows that taking walking breaks to interrupt prolonged sitting is generally safe for humans and can improve heart and metabolic health markers, such as blood pressure and insulin levels.13678

How does the treatment of walking breaks differ from other treatments for cardiometabolic health?

Walking breaks are unique because they involve interrupting long periods of sitting with short, moderate-intensity walks, which can help improve cardiometabolic health markers like insulin and triglyceride levels. This approach is different from other treatments as it focuses on breaking up sedentary time rather than just increasing overall physical activity.12389

Research Team

KD

Keith Diaz, PhD

Principal Investigator

Florence Irving Assistant Professor of Behavioral Medicine, CUIMC

YK

Ying Kuen (Ken) Cheung, PhD

Principal Investigator

Professor of Biostatistics, Department of Biostatistics, CUIMC

Eligibility Criteria

This trial is for adults who can understand English or Spanish, have no chronic conditions like heart disease or diabetes, don't take blood pressure or glucose medication, and have no musculoskeletal issues. Participants should not be allergic to common foods, follow specific diets, smoke cigarettes, or have trouble with IV access.

Inclusion Criteria

No allergies to common food allergens including wheat, eggs, milk or other dairy, gluten, fructose, peanuts or other nuts
I do not have any long-term health conditions like heart disease or diabetes.
Do not currently smoke cigarettes
See 6 more

Exclusion Criteria

I am unable to give my consent.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Experimental Condition

Participants undergo two 8-hour lab visits, one with sedentary breaks and one as a control condition, to determine the minimally effective and maximally tolerated doses of sedentary breaks.

2 lab visits (8 hours each)
2 visits (in-person)

Follow-up

Participants are monitored for safety and effectiveness after the experimental conditions.

4 weeks

Treatment Details

Interventions

  • Controlled Diet
  • Sedentary Break (Walking) Condition
  • Sitting (Control) Condition
Trial OverviewThe study aims to find the smallest effective 'dose' of activity breaks needed during an 8-hour sitting period to improve heart health and blood sugar levels. It will test different frequencies (e.g., every 30 min) and durations (e.g., 1 min) of walking breaks against a control group that remains seated.
Participant Groups
2Treatment groups
Experimental Treatment
Group I: Sedentary Break Condition > Control ConditionExperimental Treatment3 Interventions
Participants will be assigned to the sedentary break or control condition at each lab visit. If assigned to the sedentary break condition at lab visit 1, participants will be assigned to the control condition at visit 2 (and vice versa). During the lab visit, participants will wear a heart rate monitor and ambulatory blood pressure monitor, and eat a controlled diet. Participants will have an IV inserted and blood will be drawn 11 times throughout the visit. Participants will also eat a controlled diet for two days prior to the lab visit.
Group II: Control Condition > Sedentary Break ConditionExperimental Treatment3 Interventions
Participants will be assigned to the sedentary break or control condition at each lab visit. If assigned to the sedentary break condition at lab visit 1, participants will be assigned to the control condition at visit 2 (and vice versa). During the lab visit, participants will wear a heart rate monitor and ambulatory blood pressure monitor, and eat a controlled diet. Participants will have an IV inserted and blood will be drawn 11 times throughout the visit. Participants will also eat a controlled diet for two days prior to the lab visit.

Find a Clinic Near You

Who Is Running the Clinical Trial?

Columbia University

Lead Sponsor

Trials
1,529
Recruited
2,832,000+

National Heart, Lung, and Blood Institute (NHLBI)

Collaborator

Trials
3,987
Recruited
47,860,000+

Findings from Research

In a study involving 70 adults, regular activity breaks (walking for 1 minute and 40 seconds every 30 minutes) significantly reduced insulin and glucose levels after meals compared to prolonged sitting and continuous physical activity.
Regular activity breaks lowered insulin levels by 866.7 IU ยท L(-1) ยท 9 h(-1) and glucose levels by 18.9 mmol ยท L(-1) ยท 9 h(-1), demonstrating that interrupting sedentary behavior is more effective for managing post-meal metabolism than simply engaging in continuous physical activity.
Breaking prolonged sitting reduces postprandial glycemia in healthy, normal-weight adults: a randomized crossover trial.Peddie, MC., Bone, JL., Rehrer, NJ., et al.[2023]
Interrupting sedentary behavior with light-intensity activity may positively impact blood sugar levels (glycemia) in adults, according to a meta-analysis of nine experimental studies.
Observational studies suggest that breaks in sedentary behavior are associated with lower obesity metrics, independent of total sitting time, indicating potential benefits for managing adiposity.
Meta-analysis of the relationship between breaks in sedentary behavior and cardiometabolic health.Chastin, SF., Egerton, T., Leask, C., et al.[2022]
In a study of 537 adolescents aged 10 to 14, increasing the number of breaks from sedentary behavior was linked to lower body mass index (BMI), suggesting a potential strategy for managing weight in this age group.
The association between breaks in sedentary time and BMI was consistent across genders and was not influenced by nutritional status or excessive sedentary time, indicating that simply incorporating more activity breaks could be beneficial for adolescents' health.
Breaks in Sedentary Time and Cardiometabolic Markers in Adolescents.Quirino, NMML., Prazeres Filho, A., Barbosa, AO., et al.[2021]

References

Breaking prolonged sitting reduces postprandial glycemia in healthy, normal-weight adults: a randomized crossover trial. [2023]
Meta-analysis of the relationship between breaks in sedentary behavior and cardiometabolic health. [2022]
Breaks in Sedentary Time and Cardiometabolic Markers in Adolescents. [2021]
Adiposity and insufficient MVPA predict cardiometabolic abnormalities in adults. [2022]
Isotemporal Substitution Analysis of Accelerometer-Derived Sedentary Behavior and Physical Activity on Cardiometabolic Health in Korean Adults: A Population-Based Cross-Sectional Study. [2021]
Breaking up prolonged sitting with light-intensity walking improves postprandial glycemia, but breaking up sitting with standing does not. [2022]
Effects of Breaking Up Prolonged Sitting on Cardiovascular Parameters: A systematic Review. [2022]
Postprandial Insulin and Triglyceride Concentrations Are Suppressed in Response to Breaking Up Prolonged Sitting in Qatari Females. [2023]
Accumulation patterns of sedentary time and breaks and their association with cardiometabolic health markers in adults. [2021]